Gennadiy Yu. Yarin

Gennadiy Yu. Yarin

Auto-generated profile, based on publicly available information

Gennadiy Yu. Yarin

Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Urology Herald
Verified
Journal Article
Open access
PDF file
GYG. Yu. Yarin
G. Yu. Yarin
EKE. I. Kreydin
E. I. Kreydin
RSR. V. Salyukov
R. V. Salyukov
EKE. V. Kasatonova
E. V. Kasatonova
SAS. V. Astrakov
S. V. Astrakov
ГЯГ. Ю. Ярин
Г. Ю. Ярин
Introduction. Neuromodulation has proven itself in the treatment of patients suffering from idiopathic overactive bladder and non-obstructive urinary retention, who are resistant to conservative therapy. The possible use of the method in the population of patients with neurogenic lower urinary tract dysfunction (NLUTD) is of undoubted clinical interest.Objective. To analyze the current possibilities and features of neuromodulation in a cohort of patients with NLUTD.Materials and methods. Original research materials published in the PubMed, eLibrary, SciVerse (ScienceDirect), Scopus, Medline, EMBASE databases, websites of professional associations without restrictions on the date of publication were used. Sixty sources were selected for citation, with preference given to systematic reviews, meta-analyses and RCTs .Results. In relation to NLUTD, transcranial and peripheral magnetic stimulation, intravesical electrical stimulation, tibial, pudendal electrical stimulation, and stimulation of the dorsal pudendal nerve, as well as sacral and epidural methods of neurostimulation are considered.Conclusion. The current literature optimistically presents the experience of using neuromodulation in the NLUTD patient population with the largest evidence base for invasive sacral and tibial stimulation. The studies are based on heterogeneous populations, limited by small sample sizes with insufficient descriptive part of the degree and severity of neurological diseases, and it should be considered when forming guidelines. However, the lack of other suitable therapies and promising initial results indicate the importance of further efforts to improve the applied methods of neuromodulation. Further studies are needed with larger sample sizes, better classification of diseases, and controlled study design

24 September 2025 in Kazan medical journal
Verified
Journal Article
Open access
PDF file
IMIgor Maiborodin
Igor Maiborodin
GYGennadiy Yu. Yarin
Gennadiy Yu. Yarin
MRMaxim E. Ryaguzov
Maxim E. Ryaguzov
ATAnton Yu. Tsukanov
Anton Yu. Tsukanov
BSBoris V. Sheplev
Boris V. Sheplev
ЦЮЦуканов Антон Юрьевич
Цуканов Антон Юрьевич
Multipotent stromal (stem) cells are currently the subject of extensive research. Initially, special attention was given to their reparative properties; however, in recent years, the focus switched toward their immunomodulatory effects. Multipotent cells inhibit T cell proliferation (directly and via exosomes), suppress proinflammatory cytokine production, and activate anti-inflammatory cytokine synthesis. Owing to these effects, cell technologies are currently used in the treatment of Huntington disease, multiple sclerosis, autoimmune encephalomyelitis, scleroderma, systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis, and other disorders. Furthermore, multipotent stromal cells have demonstrated efficacy in acute respiratory distress syndrome models, supporting their potential use in the treatment of COVID-19 complications. They interact with target cells via both paracrine signaling and direct cell–cell interactions. However, multipotent cell-driven immunoregulation and immunosuppression mechanisms are still poorly understood. The use of multipotent cells is highly dependent on the cell source and their functions in vivo; moreover, functional capabilities of stem cells are known to decline with age. It is also essential to consider potential complications of immunomodulatory effects of multipotent stromal cells, including long-term, severe immunosuppression, which may result in prolonged inflammation in infections and facilitate the progression of malignant neoplasms. For the effective use of multipotent cells, changes in gene expression induced by cell culture and various disorders must be taken into account. Further research is warranted into the mechanisms behind the immunomodulatory effect of multipotent stromal cells, as well as indications and contraindications for cell therapy in humans and animals. Moreover, it will be beneficial to investigate ways to control the functions of stem cells in various microenvironments.

14 February 2020 in Novosti Khirurgii
Verified
Journal Article
Closed access
IMIgor Maiborodin
Igor Maiborodin
TMT.V. Mikheeva
T.V. Mikheeva
GYG.Yu. Yarin
G.Yu. Yarin
NTNovosibirsk Research Institute of Traumatology and Orthopedics named after Ya.L. Tsivyan
Novosibirsk Research Institute of Traumatology and Orthopedics named after Ya.L. Tsivyan
SKS.V. Khomenyuk
S.V. Khomenyuk
ASAndrey Ivanovich Shevela
Andrey Ivanovich Shevela

30 September 2025 in Urology Reports (St. - Petersburg)
Verified
Journal Article
Closed access
PDF file
IMIgor Maiborodin
Igor Maiborodin
ATAnton Yu. Tsukanov
Anton Yu. Tsukanov
GYGennadiy Yu. Yarin
Gennadiy Yu. Yarin
BSBoris V. Sheplev
Boris V. Sheplev
ASAndrey Ivanovich Shevela
Andrey Ivanovich Shevela
ЯЮЯрин Геннадий Юрьевич
Ярин Геннадий Юрьевич
The use of multipotent stem cells opens new possibilities in various fields of medicine, including urology. This article provides a detailed overview of experimental and clinical studies demonstrating the efficacy of multipotent stem cells in the treatment of urologic diseases. Multipotent stem cells have been shown to reduce the severity of renal failure, improve urinary incontinence, and alleviate both organic and functional bladder disorders, ischemia–reperfusion injuries of the testes, erectile dysfunction, and penile enlargement. Moreover, they have proven effective in Peyronie disease and ischemic priapism. New tissue-engineering approaches for cystoplasty and urethral stricture repair are described, in which multipotent stem cells are adsorbed onto various graft materials before surgery. The high therapeutic efficacy of cell therapy is most likely associated with its ability to stimulate regeneration and angiogenesis, restore microcirculation and innervation, inhibit inflammation and apoptosis, and reduce tissue injury and fibrosis. Only a small fraction of implanted multipotent stem cells remain viable and differentiate into smooth muscle and endothelial cells. The primary effect of multipotent stem cells is most likely mediated by paracrine mechanisms. No severe adverse effects have been reported following the clinical application of multipotent stem cells.

28 September 2019 in Klinicheskaia khirurgiia
Verified
Journal Article
Open access
PDF file
IMIgor Maiborodin
Igor Maiborodin
SKS. V. Khomenyuk
S. V. Khomenyuk
TMT. V. Mikheeva
T. V. Mikheeva
GYG. Yu. Yarin
G. Yu. Yarin
VMV. I. Maiborodina
V. I. Maiborodina
ASAndrey Ivanovich Shevela
Andrey Ivanovich Shevela
Некоторые особенности имплантации в условиях применения клеточных технологий